Clinical Trial Update: Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

View source ↗

Summary

A pilot trial evaluating EyeArt, an automated diabetic retinopathy screening tool, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• EyeArt

Snippet

Sponsor: Eyenuk, Inc. | Conditions: Diabetic Retinopathy | Status: COMPLETED